Dowiedzieć się o najlepszych cenach i klinikach w leczeniu polipów nosa w Włoszech w 2026 roku

Italy offers advanced treatments for nasal polyps including monoclonal antibodies like Dupilumab and minimally invasive surgery. Patients access Functional Endoscopic Sinus Surgery (FESS) at Joint Commission International-accredited facilities. Medical management focuses on nasal corticosteroids and biologics. These therapies effectively reduce inflammation and prevent recurrence in severe cases.

• Biologic therapy: AIFA-approved Dupilumab and Mepolizumab target severe eosinophilic inflammation.
• Surgical gold standard: FESS removes polyps with endoscopes via day surgery.
• Medication management: Steroid sprays and oral prednisone cycles manage symptom burden effectively.
• Specialized techniques: Preservation rhinoplasty and laser vaporization offer less invasive alternative options.

Bookimed Expert Insight: Italian clinics like Ospedale San Carlo di Nancy balance massive patient volumes with high specialization. Dr. Nicola Vione at Santa Caterina da Siena uses preservation techniques to ensure faster recovery. Patients should look for centers linked to major research foundations for access to the latest biologics. For example, Mater Olbia Hospital combines expertise from Fondazione Policlinico Universitario Agostino Gemelli IRCCS.

Patient Consensus: Patients note that choosing private care avoids the 6-12 month public health wait times. Many emphasize that daily saline rinses are essential to prevent the high risk of recurrence.

Italy offers advanced nasal polyp care through specialized ENT departments in Rome, Milan, and Naples. Leading facilities like Ospedale San Carlo di Nancy and Agostino Gemelli University Policlinic utilize endoscopic sinus surgery (FESS). These centers integrate biological therapies for chronic cases to prevent polyp recurrence.

• Specialized surgery: FESS techniques minimize recovery time and improve breathing.
• Expert diagnosis: University hospitals use advanced endoscopic instruments for evaluations.
• Biological therapy: Modern treatments like Dupixent target the underlying inflammation.
• Rapid access: Private clinics often provide consultations within 2 to 4 weeks.

Bookimed Expert Insight: Patients seeking specialized ENT care in Italy should consider the collaborative nature of major institutions. For example, Mater Olbia Hospital was created through a partnership with the Agostino Gemelli University Policlinic. This allows patients to access university-level expertise in a modern, international setting designed for global healthcare standards.

Patient Consensus: Patients note that choosing private care or specialized university centers is essential to avoid wait times exceeding 6 months. High-volume surgeons in cities like Milan and Rome are preferred for their endoscopic expertise.

Qualifying for Mepolizumab in Italy requires a clinical diagnosis of severe eosinophilic rhinosinusitis with nasal polyps. Patients must demonstrate blood eosinophil levels above 150–300 cells/μL. Documentation must prove standard treatments like corticosteroids or surgery failed to control symptoms before enrollment in the AIFA registry.

• Treatment history: Documented failure of nasal corticosteroids for over 6 months is mandatory.
• Eosinophil levels: Blood tests must show counts often reaching or exceeding 400 cells/μL.
• Specialist eligibility: Prescription must come from authorized centers with pulmonary or immunology specialists.
• AIFA monitoring: Specialists must register patients in the national system for medication reimbursement.

Bookimed Expert Insight: Italian clinics like Ospedale Santa Maria are accredited for public health services. This is vital since biologics require AIFA registry clearance. Doctors like Dr. Nicola Vione emphasize specialized ENT expertise in Turin and other major hubs. This focus on surgical and pathological qualifications ensures patients receive the specific eosinophilic coding required for drug approval.

Patient Consensus: Patients note that having asthma alongside polyps often speeds up approval significantly. Many recommend seeing an allergist early because some ENTs may focus only on repeating surgery instead of starting biologics.

Endoscopic sinus surgery is fully covered by the Italian National Health Service (SSN) when medically necessary. Patients must obtain a referral from a general practitioner and an otolaryngology specialist evaluation. Costs are typically borne by the state, though minor co-payments apply for diagnostic tests.

• Referral process: Visit a general practitioner for an initial otolaryngology specialist referral.
• Surgical approval: An ENT specialist must confirm the procedure is clinically essential.
• Mandatory documentation: Patients need a valid Health Insurance Card (Tessera Sanitaria) for access.
• Potential co-payments: Diagnostic tests or consultations may require fees of €36 to €100.

Bookimed Expert Insight: While public coverage is universal, facility type significantly impacts access speed. Clinics like Ospedale San Carlo di Nancy are SSN-accredited and handle 15,000 patients annually. Choosing these accredited centers often provides a middle ground between long public waitlists and high private costs. Specialist Dr. Nicola Vione works within the public system, demonstrating high-level expertise is available under SSN coverage.

Patient Consensus: Patients note that while surgery is free, waiting lists in Rome can reach 8 months. Many recommend pushing for urgent classification from a family doctor to accelerate the surgical timeline.

A typical biologic therapy work-up for nasal polyps in Italy involves extensive diagnostics to confirm severity before the first dose. Travelers undergo ENT endoscopy, CT scans, and specific blood tests like IgE levels and eosinophil counts. Italy ranks 8th globally for medical tourism, offering high-standard private care.

• Diagnostic screening: Mandatory ENT endoscopy and CT scans confirm polyp severity and surgical history.
• Blood panels: Testing includes IgE levels, kidney function, and eosinophil counts for eligibility.
• Immunology review: Clinics verify allergy panels and skin prick tests before starting therapy.
• Treatment stay: Initial cycles require 5–7 days, while later doses allow same-day travel.

Bookimed Expert Insight: Italian private clinics like Ospedale San Carlo di Nancy handle over 15,000 hospitalizations annually and provide efficient outpatient workflows. While public hospitals may take two days for basic bureaucracy, choosing a specialized private center in Rome or Milan often allows for a same-day loading dose and immediate 1–2 hour monitoring. This significantly reduces necessary hotel nights for international patients during follow-up cycles.

Patient Consensus: Patients emphasize completing bloodwork 4–6 weeks early to avoid travel delays. Many travelers note the importance of a SNOT-22 score above 40 to ensure they meet the clinical criteria for treatment before flying.